Value Vision

A Boutique Investment Bank
Indian banks may need to raise up to $ 50 billion (about Rs 2.5 lakh crore) of additional equity under the Basel III capital regulations announced by the RBI on top of retained earnings, a Fitch study said.

"Most of the requirement is back-ended, with over 75 per cent needed to be added between 2015-16 and 2017-18. The additional equity reflects growth capital as well as a buffer above the regulatory minimum," as per Fitch study.

The Reserve Bank of India announced measures to bolster foreign currency inflows following a sharp fall in the rupee, although traders said the moves may not be enough to stem further near-term weakness.

The rupee is down about 9 percent since the start of March and suffered steep falls in the last three sessions before recovering its daily losses on Friday. The Reserve Bank of India is believed to have stepped into the market to defend the currency. Encouraging dollar inflows would lend support to the currency.

PE Favourites
  • Business Services
  • Consumer Durables
  • Healthcare
  • Food Processing
  • Hospitality
  • Education
  • Defence Services
M&A opportunities

Buy Side:
  • Water and waste water management
  • Cloud computing and Data Analytics – US / Europe
Sell Side:
  • Higher Education – Business Management and Engineering

  • Sebi allows unified licence for stock and commodity broking
  • ICICI Prud Balanced Fund: Diversified portfolio, consistent outperformance
  • Nifty Pharma index hits 7-week high
  • US stocks slip from record levels as Apple, Fed view weigh
  • Rupee crashes 54 paise to 10-week low at 64.81 vs dollar
  • NSE to auction investment limit for Rs 2,220-cr corporate bonds
  • Granules India's QIP issue open for sale at floor price of Rs 127.63
  • investors bag up to eight-fold returns
  • makes a quiet debut; ends 8% lower vs IPO price of Rs 985
  • Tax evasion via stocks: Sebi revokes ban on 82 entities
  • SMS Pharma, Orchid Pharma, ITI among 9 stocks frozen in 20% upper circuit
  • Sensex pares losses to end flat, Nifty above 10,100; Dr Reddy's up 7%
  • Bhagiradha Chemicals zooms 41% in two days on fund raising plan
  • ITI hits 52-week high; company lowest bidder for contract worth Rs 7,000 cr
  • Nifty Pharma index hits 7-week high; Divi's Lab zooms over 50% in one month
  • Yes Bank turns ex-stock split in the ratio of 5 for 1; shares hit new high
  • Dr Reddy's Labs gains as Srikakulam SEZ Unit II get EIR from USFDA
  • Novartis India surges 7% as board mulls share buyback
  • One more rate hike likely this year! Key takeaways from US Fed policy
  • Equity MFs stick to their top picks as market trades at historical highs
  • Government stake in NTPC drops to below 63%
  • Govt's electric vehicle plan is electrifying these stocks
  • Reliance Home Finance to list on bourses on Friday
  • Matrimony.Com to debut on bourses tomorrow
  • PE investments take Jan-Aug deal tally to $13.8 bn, e-tail contributes 51%
  • Sensex ends flat, Nifty settles below 10,150 ahead of Fed outcome
  • PSU banks gain; Bank of Baroda up 4% after huge block deal
  • IUC cut to dent margins of Bharti and Idea; bonanza for RJio, say analysts
  • Sebi revokes ban on 114 entities, says no evidence of tax evasion
  • SMS Lifesciences locked in upper circuit; zooms 252% since listing
  • Bharti Airtel recovers after initial fall; RIL at new high as TRAI cuts IUC
  • Bharati Defence, Walchandnagar among 10 stocks rallying over 50% in a week
  • Tyre stocks rally up to 11% after govt imposes anti-dumping duty
  • Divi's Labs surges 6% on successful USFDA inspection of Unit-2
  • L&T gains on winning contract worth Rs 1,700 crore in Kuwait